News >

Bekaii-Saab Highlights Emerging Agents in Pancreatic Cancer Pipeline

Danielle Bucco
Published: Friday, Mar 30, 2018

Tanios Bekaii-Saab, MD
Tanios Bekaii-Saab, MD
The increasing incidence of pancreatic cancer could make the malignancy the second-leading cause of cancer-related death in the United States, making it imperative to find new treatment options, explains Tanios Bekaii-Saab, MD.

State of the Science Summit™ on Gastrointestinal Cancers, Bekaii-Saab, a professor of medicine at Mayo Clinic, discussed emerging treatments offering hope to patients with pancreatic cancer.

OncLive: Please discuss the current state of pancreatic cancer treatment.

Bekaii-Saab: Pancreatic cancer is leading the trend in terms of increasing incidence. The mortality of pancreatic cancer continues to be on the rise. In fact, if nothing is done to change this, it will be the second cancer killer in the United States, creating an urgency to find new treatments. 
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Navigating Treatment Decisions in Pancreatic Cancer: Key QuestionsJun 29, 20191.5
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Publication Bottom Border
Border Publication
x